secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0000950170-23-019669
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q1 revenue $17.5M (+96% YoY); raises FY2023 revenue and margin guidance
-------------------------------------------------------------------------------

- Revenue $17.5M, up 96% YoY; gross margin improved to 59% from 42%.
- Net loss $(13.2)M ($0.42/share) vs $(17.6)M loss a year ago; adjusted loss $(0.31)/share.
- LAL procedure volumes 10,523 (+153% YoY); LDD installed base grew to 456 units (+85% YoY).
- Raised ~$64.5M net proceeds from equity offerings; cash & investments $153.9M.
- FY2023 guidance raised: revenue $79-84M (prior $78-83M); gross margin 56-58% (prior 52-54%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023019669/0000950170-23-019669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023019669/rxst-20230509.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-019669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer